Dr. David H. Johnson
Dr. Julie M. Vose
The task force is led by ASCO Past President David H. Johnson, MD, FACP, FASCO, and its members include many prominent ASCO leaders, such as 2015–2016 ASCO President Julie M. Vose, MD, MBA, FASCO; Robert D. Siegel, MD, FACP; Nathan M. Shumway, DO, FACP; Melissa S. Dillmon, MD; and Lecia V. Sequist, MD, MPH. Staff members include Jamie H. Von Roenn, MD, FASCO, and Lisa Johnson, MHS, MT(ASCP)SC.
The task force will create a formal proposal that addresses ASCO members’ top concerns about the ABIM changes. Toward this goal, the task force met on March 2 and began drafting a proposal. The task force aims to have a final report ready for the ASCO Board of Directors by November, which they will subsequently present to the ABIM.
“With the recently released Assessment 2020 Task Force recommendations, ABIM appears committed to restructuring its MOC program,” Dr. Johnson said. “The overarching goal is to ensure the program is relevant to practicing oncologists and hematologists. The ASCO MOC Task Force will work with ABIM to help ensure the restructured MOC program is truly representative of what our members see and do in their daily practices.”
In order to ensure that the proposal accurately addresses members’ concerns, the task force welcomes member input, which can be emailed to email@example.com. “Please continue to provide your insights and concerns regarding the ongoing changes in the redesign of the recertification process,” Dr. Vose said. “We are committed to developing a recertification process that is efficient, meaningful, and meets the continuing education goals of practicing oncologists.”